Endometriosis prophylaxis and treatment with the newly developed xenogenic immunomodulator RESAN in an animal model

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 142, Issue 2, 2009, Pages 145-148

  Szymanowski, Krzysztof ^a   Chmaj Wierzchowska, Karolina ^a   Yantczenko, Andrey ^b   Niepsuj Biniaś, Joanna ^a   Florek, Ewa ^a   Opala, Tomasz ^a   Murawski, Marek ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b The Scientific Research Enterprise RESAN   (Belarus)

^c UNIVERSITY OF WROC AW   (Poland)

Author keywords

Endometriosis; Immunology; Prophylaxis; Rat; Treatment

Indexed keywords

IMMUNOMODULATING AGENT; RESAN VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOSIS; FEMALE; HISTOPATHOLOGY; LAPAROTOMY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT; VACCINATION;

EID: 59249105387     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.09.017     Document Type: Article

References (25)

1. Audebert A., Bäckström T., Barlow D., et al. Endometriosis 1991: a discussion document. Hum Reprod 7 (1992) 423-435
2. D'Hooghe T., Xiao L., and Hill J. Cytokine profiles in autologous peritoneal fluid and peripheral blood of women with deep and superficial endometriosis. Arch Gynecol Obstet 265 (2001) 40-44
3. Redwine D. Was Sampson wrong?. Fertil Steril 78 (2002) 686-693
4. Vinatier D., Cosson M., and Dufour P. Is endometriosis an endometrial disease?. Eur J Obstet Gynecol Reprod Biol 91 (2000) 113-125
5. Mangtani P., and Booth M. Epidemiology of endometriosis. J Epidemiol Community Health 47 (1993) 84-88
6. Farquhar C.M. Extracts from the "clinical evidence" Endometriosis. BMJ 320 (2000) 1449-1452
7. D'Hooghe T.M., Debrock S., Hill J.A., and Meuleman C. Endometriosis and subfertility: is the relationship resolved?. Semin Reprod Med 21 (2003) 243-254
8. Harris J.E., Ryan L., Hoover H.C., et al. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Study (E5283). J Clin Oncol 58 (2000) 215-218
9. Knutson K.L., Schiffman K., Cheever M.A., and Disis M.L. Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity. Clin Cancer Res 8 (2002) 1014-1018
10. Itil I.M., Cirpan T., Akercan F., et al. Effect of BCG vaccine on peritoneal endometriotic implants in a rat model of endometriosis. Aus NZ J Obstet Gynecol 46 (2006) 38-41
11. Gul A., Yaspar T., and Ugras S. BCG vaccination to prevent implantation of endometriosis: an experimental study in rats. Eur J Obstet Gynecol Reprod Biol 98 (2001) 209-212
12. Balasch J., Creus M., Fabregas F., et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Hum Reprod 12 (1997) 2046-2050
13. Yantchenko VV, Yantchenko AV, Yantchenko LK. Imitators of the tumor antigens. The patent committee RB, appl. N970547; 1997.
14. Florek E., Szymanowski K., Wrzosek J., Piekoszewski W., Biczysko W., and Marszałek A. The influence of simultaneous whole body exposure to cigarette smoke and low-protein diet feeding on fertility, reproduction and progeny of rats. Hum Exp Toxicol 21 (2002) 615-621
15. Je{ogonek}drzejczak P., Szymanowski K., Skrzypczak J., and Pisarski T. [ekspermantalny model endometriozy u szczurów] The experimental model of endometriosis in rats. Ginek Pol 61 (1990) 387-391
16. Szymanowski K., Florek E., Mikołajczyk M., and Skrzypczak J. Integrin pattern in rats endometrium after endometriosis induction. Pol J Gynaecol Invest 5 (2002) 293-298
17. Szymanowski K., Mikołajczyk M., Ra{ogonek}czyńska P., Florek E., and Skrzypczak J. Integrin pattern in rats endometrium after endometriosis excision. Pol J Gynaecol Invest 5 (2002) 299-302
18. Szymanowski K., Mikołajczyk M., and Skrzypczak J. Apoptosis expression in rats' endometrium after surgical induction of endometriosis. Ginek Pol 74 (2003) 262-266
19. The patent committee of Republic of Belarus, No. 5942; 1997.
20. Dmowski W.P., and Braun D.P. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18 (2004) 245-263
21. Szymanowski K. Apoptosis pattern in human endometrium in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol 132 (2007) 107-110
22. Hoover Jr. H.C., Brandhorst J.S., Peters L.C., et al. Adjuvant active specific immunotherapy for human colorectal cancer: 6, 5-year median follow-up of phase III prospective randomized trial. J Clin Oncol 11 (1993) 390-399
23. Mittelman A., Chen Z.J., Yang H., Wong G.Y., and Ferrone S. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci USA 15 (1992) 466-470
24. Schultz N., Oratz R., Chen D., et al. Effect of DETOX as an adjuvant for melanoma vaccine. Vaccine 13 (1995) 503-508
25. Helling F., Zhang S., Shang A., et al. GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res 55 (1995) 2783-2788